Mr Mrs Miss Ms Dr Other

Dr
Aron
Ferenczi

Trainee Patent Attorney

Glasgow Office

Life sciences

Telephone. +44 (0)141 229 5800
Email. [email protected]
Vcard
Linkedin

Experience

Aron joined HGF’s Glasgow office in January 2023 as a Trainee Patent Attorney in Life Sciences.

A graduate of The University of Edinburgh and recipient of multiple scholarships and awards, his doctoral studies focused on gene editing and DNA repair in algae which led to first-author publications in PNAS and Nature Communications, a book chapter and a patent application. He has several years’ experience working in biotechnology start-ups in scientific and business development roles.

He is an empathic listener with an analytical and strategic mindset who is motivated by seeing the societal and commercial impacts of transformative life sciences innovation.

Specialisms

Industries

Services

Qualifications

Trainee

BSC

Biological Sciences (Plant Science), First Class Honours, The University of Edinburgh

MSC

Bioinformatics, Distinction, The University of Edinburgh

PHD

Cell and Molecular Biology, The University of Edinburgh

Recognition

Lang Scholarship Prize

Best dissertation project in Plant Sciences awarded by The University of Edinburgh

Highly Skilled Workforce Scholarship

MSc scholarship awarded by The University of Edinburgh

Doctoral Training Partnership (DTP)

PhD scholarship awarded by the Biotechnology and Biological Sciences Research Council (BBSRC)

Publications

Chloroplast phosphate transporter CrPHT4-7 regulates phosphate homeostasis and photosynthesis in Chlamydomonas

View publication online

Mechanistic and genetic basis of single-strand templated repair at Cas12a-induced DNA breaks in Chlamydomonas reinhardtii

View publication online

Download publication PDF

Related News

New Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Investing in Patents for Space Tech: Safeguarding Innovations in the Space Sector

The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …

Read article

End of EPO "10 day rule" from 1 November 2023 – 4 weeks to go

Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them.   This means that communications are deemed to …

Read article
Event - 21st, 28th November 2023

Dresden & Salzburg Seminar: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …

Event details
Event - 26th September 2023

Bioforward OBN Conference 2023

Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …

Event details

AI-Powered Personalised Medicine

The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us